Journals / Turkish Journal of Clinics and Laboratory / 2019 / Cilt: 10 - Sayı: 4

Cardiovascular causes of dementia

Demansın kardiyovasküler sebepleri

Pages
515–518
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Prevention and treatment of cardiovascular disease in early ages and the choice of medications may affect prognosis of dementia as well as primary cardiovascular disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Dementia, as a geriatric syndrome, is an increasing concern as the ageing population grows worldwide and it is more common due to enhanced diagnostic tools.
📊
Key Findings & Data:The incidence of dementia is low before 75 years of age and increases exponentially with age, even in the oldest age groups.
💡
Conclusion & Impact:Prevention and treatment of cardiovascular disease in early ages and the choice of medications may affect prognosis of dementia as well as primary cardiovascular disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:kardiyovasküler · demans · yaşlı

Abstract

Dementia, as a geriatric syndrome, is an increasing concern as the ageing population grows worldwide and it is more common due to enhanced diagnostic tools. The incidence of dementia is low before 75 years of age and increases exponentially with age, even in the oldest age groups. Dementia and heart health are in close relationship. Coronary artery disease risk factors, atrial fibrillation, heart failure and some medications given for cardiovascular diseases can lead to dementia via systemic effects and also worsen dementia. Prevention and treatment of cardiovascular disease in early ages and the choice of medications may affect prognosis of dementia as well as primary cardiovascular disease.

Özet

Geriatrik bir sendrom olan demans, dünya çapında yaşlı popülasyondaki artış ve gelişmiş tanı araçları sebebiyle giderek artan bir sağlık problemidir. Demans insidansı 75 yaşından önce düşüktür ve ileri yaş gruplarında bile yaşla birlikte katlanarak artmaktadır. Demans ve kalp sağlığı yakın ilişki içindedir. Koroner arter hastalığı risk faktörleri, atriyal fibrilasyon, kalp yetmezliği ve kardiyovasküler hastalıklar için verilen bazı ilaçlar sistemik etkiler ile demansa neden olabilir ve demansı kötüleştirebilir. Erken yaşta kardiyovasküler hastalıkların önlenmesi ve tedavisi için uygun ilaç seçimi primer kardiyovasküler hastalığın yanı sıra demans prognozunu etkileyebilir.

🔖

Cite This Article

DEMİR, F. A. (2019). Cardiovascular causes of dementia. Turkish Journal of Clinics and Laboratory, Cilt: 10 - Sayı: 4, 515–518. https://ajindex.com/articles/372957

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Daviglus ML, Bell CC, Berrettini W et al. NIH state-of-the science conference statement: preventing Alzhemier' s disease and cognitive decline. NIH Consens State Sci Statements. 2010; 27: 1-27
  2. Kızıl ET. Other Dementias. J Psychiatry-Special Topics 2017; 10: 37-43 3. Fratiglioni L, Viitanen M, von Strauss E, Tontodonati V, Herlitz A, Winblad B. Very old women at highest risk of dementia and Alzheimer’s disease: incidence data from the Kungsholmen project, Stockholm. Neurology1997; 48: 132–38
  3. Rowe CC, Ellis KA, Rimajova M, Bourgeat P et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging 2010; 31: 1275–83
  4. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 2005; 64: 277–81
  5. Kivipelto M, Helkala EL, Laakso MP et al. Midlife vascular risk factors and Alzheimer’s disease in later life: longitudinal, population based study. BMJ 2001; 322: 1447–51
  6. Love S, Miners JS. Cerebrovascular disease in aging and Alzhemier's disease. Acta Neuropathol 2016; 131: 645-58
  7. Rönnemaa E, Zethelius B, Lannfelt L, Kilander L.Vascular risk factors and dementia: 40 year follow-up of a population-based cohort. Dement Geriatr Cogn Disord 2011; 31:460-66
  8. Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik RJ. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu Asia Aging Study. JAMA 1995; 274: 1846-51
  9. Goldenstein FC, Allan I. Levery, Steenland NK. High Blood Pressure and Cognitive Decline in Mild Cognitive Impairment. J Am Geriatr Soc 2013; 61: 67-73
  10. Mahoney JR, Verghese J, Goldin Y, Lipton R, Holtzer R. Alerting, orienting, and executive attention in older adults. J.Int Neuropsychol Soc 2010; 16: 877-89
  11. Gasecki D, Kwarciany M, Nyka W, Narkiewic K. Hypertension, Brain Damage and Cognitive Decline. Curr Hypertens Rep 2013; 15: 547-58
  12. Raz N, Rodrigue KM, Kennedy KM, Acker JD. Vascular health and longitudinal changes in brain and cognition in middle-aged and older adults. Neuropsychology 2007; 21: 149-57
  13. Waldenstein SR, Rice SC, Thayer JF, Najjar SS, Scuteri A, Zonderman AB. Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. Hypertension 2008; 51: 99-104 15. Gorelick PB, Scuteri A, Black SE et al.Vascular contributions to cognitive impairment and dementia: a statement for heal